Kursprognose für United Therapeutics Corp (UTHR)UTHRUnited Therapeutics Corp

Alphio's UTHR stock price prediction model matches the current United Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $578.48 (+2.66%). The 1-week path is $592.00 (+5.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

United Therapeutics Corp is currently a hold. The stock is priced at $533.12, which is below several analyst price targets, including $728 from BTIG and $708 from RBC Capital. However, the RSI is at 45.857, indicating that the stock is neither overbought nor oversold, suggesting caution. The recent settlement with Liquidia has removed significant legal uncertainties, but the stock has seen a 2.92% decline over the last five days, indicating potential short-term volatility. The main risk is the Goldman Sachs target of $321, representing a 34% downside from current levels, which investors should consider before making a decision.

United Therapeutics Corp (UTHR) last closed at $563.49, gaining +1.74%. These facts feed the 1-day and 1-week UTHR price prediction above.